Christopoulos P, Prawitz T, Hong JL, Lin HM, et al. Indirect comparison of mobocertinib and real-world therapies for pre-treated non-small cell lung cancer with EGFR exon 20 insertion mutations. Lung Cancer 2023;179:107191.
PMID: 37058788